Taft Wins at the Federal Circuit
Subscribe For Updates
Type: News Date: 06/24/2015
On June 23, the United States Court of Appeals for the Federal Circuit affirmed in favor of numerous generic pharmaceutical companies in a patent case against Pfizer. At issue was one of the key patents protecting Pfizer’s drug Celebrex® from generic competition. Taft represented Apotex Inc., one of the largest generic pharmaceutical manufacturers in the world. Read the decision here.
In This Article
You May Also Like
Taft Adds Pharma and Litigation Attorneys in Chicago Four Taft Intellectual Property Attorneys Recognized in WTR 1000 2023